Safety and Efficacy of Teneligliptin in Patients with Type 2 Diabetes Mellitus and Impaired Renal Function: Interim Report from Post-marketing Surveillance

INTRODUCTION: Teneligliptin is a novel oral dipeptidyl peptidase-4 inhibitor for the treatment of type 2 diabetes mellitus (T2DM). Safety and efficacy of teneligliptin have been demonstrated in clinical studies; however, data supporting its use in patients with moderate or severe renal impairment ar...

Descripción completa

Detalles Bibliográficos
Autores principales: Haneda, Masakazu, Kadowaki, Takashi, Ito, Hiroshi, Sasaki, Kazuyo, Hiraide, Sonoe, Ishii, Manabu, Matsukawa, Miyuki, Ueno, Makoto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5984919/
https://www.ncbi.nlm.nih.gov/pubmed/29637459
http://dx.doi.org/10.1007/s13300-018-0416-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5984919/
https://www.ncbi.nlm.nih.gov/pubmed/29637459
http://dx.doi.org/10.1007/s13300-018-0416-2

Ejemplares similares